Orthopediatrics (KIDS) Research & Development (2016 - 2026)
Orthopediatrics (KIDS) posted quarterly Research & Development of $2.2 million for Q1 2026, down 5.1% year-over-year from $2.4 million in Q1 2025, and up 104.93% quarter-over-quarter from -$45.2 million in Q4 2025.
Orthopediatrics (KIDS) Research & Development (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has reported Research & Development for 11 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 5.1% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at -$21.6 million (down 123.47% YoY), while the FY2025 annual figure was $9.1 million, down 85.84% from the prior year.
- Research & Development improved to $2.2 million in Q1 2026 per KIDS's latest filing, from -$45.2 million in the prior quarter.
- Across five years, Research & Development topped out at $56.2 million in Q4 2024 and bottomed at -$45.2 million in Q4 2025.
- Historically, Research & Development has averaged $8.5 million across 5 years, with a median of $2.6 million in 2023.
- Annual changes were most pronounced in 2023 — Research & Development soared 1714.36% — and 2025, when it tumbled 180.5%.
- Orthopediatrics' Research & Development stood at $2.5 million in 2022, then jumped by 1714.36% to $44.9 million in 2023, then rose by 25.25% to $56.2 million in 2024, then sank by 180.5% to -$45.2 million in 2025, then soared by 104.93% to $2.2 million in 2026.
- Business Quant data shows KIDS's Research & Development at $2.2 million in Q1 2026, -$45.2 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Orthopediatrics | 629.23 Mn | 583.35 Mn | 52.37 Mn | 21.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.29 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | -45.23 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 19.10 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 56.18 Mn |
| Sep 30, 2024 | 16.75 Mn |
| Jun 30, 2024 | 16.59 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 44.85 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 2.47 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 12.43 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 35.74 Mn |
| Sep 30, 2021 | 1.30 Mn |